Ebola therapies: an unconventionally calculated risk.
Elemento
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicaciónTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Título
Ebola therapies: an unconventionally calculated risk.
Materia
Descripción
This article reviews the testing of Ebola therapies during the outbreak.
Autor
Fecha
2019-01-24
Tipo
Citación
Fallah, M. P., and L. A. Skrip. 2019. "Ebola therapies: an unconventionally calculated risk." Lancet (London, England) 393 (10174):850-2.
Resumen
The current outbreak of Ebola virus disease in the Democratic Republic of the Congo, uninterrupted since August, 2018, is the largest to date in a country that has had nine outbreaks since 1976 and contained the virus each...
Accesibilidad
Free online on journal website. © 2019 Elsevier Ltd. All rights reserved.
Was this resource helpful?